8HX Stock Overview
Operates a social e-commerce mobile platform in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Akso Health Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.77 |
| 52 Week High | US$2.54 |
| 52 Week Low | US$0.48 |
| Beta | 0.20 |
| 11 Month Change | 1.99% |
| 3 Month Change | -9.94% |
| 1 Year Change | -8.33% |
| 33 Year Change | -68.44% |
| 5 Year Change | -54.97% |
| Change since IPO | -96.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8HX | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -4.3% | 0.2% | 0.8% |
| 1Y | -8.3% | 13.9% | 8.6% |
Return vs Industry: 8HX underperformed the German Healthcare industry which returned 13.9% over the past year.
Return vs Market: 8HX underperformed the German Market which returned 8.6% over the past year.
Price Volatility
| 8HX volatility | |
|---|---|
| 8HX Average Weekly Movement | 18.5% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8HX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8HX's weekly volatility has decreased from 25% to 18% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 9 | Linda Wang | www.ahgtop.com |
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscope.
Akso Health Group Fundamentals Summary
| 8HX fundamental statistics | |
|---|---|
| Market cap | €133.94m |
| Earnings (TTM) | -€8.57m |
| Revenue (TTM) | €2.29m |
54.8x
P/S Ratio-14.6x
P/E RatioIs 8HX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8HX income statement (TTM) | |
|---|---|
| Revenue | US$2.41m |
| Cost of Revenue | US$2.29m |
| Gross Profit | US$122.13k |
| Other Expenses | US$9.18m |
| Earnings | -US$9.06m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.054 |
| Gross Margin | 5.06% |
| Net Profit Margin | -375.22% |
| Debt/Equity Ratio | 1.4% |
How did 8HX perform over the long term?
See historical performance and comparison